In this Issue:

• Welcome to San Diego and the 2024 World Conference on Lung Cancer
• Joint IASLC-CSCO-CAALC Session to Explore Global Scope of Lung Cancer Prevention, Evidence-Based Medicine
• Opening Plenary to Shine Spotlight on Solutions to Improve Health Equity
• 2024 Distinguished Service Award Recipients Honored During Opening Plenary Session
• 2024 IASLC CT Screening Symposium
• LATAM Workshop: Challenges and Future of Lung Cancer in Latin America
• Tonight’s Activities Offer Opportunity to Network, Catch Up with Colleagues
• IASLC President-Elect Reflects on Importance of Prevention, Screening, Biomarker Testing and More
• Empowering Change and Amplifying Impact Through Research Advocacy Activities
• Meet the Expert: Digital Health for Supportive Care Delivery
• First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology
• Action Needed to Improve Gender Equity in Thoracic Oncology
• Learn and Network During Poster Viewing Events
• Analysis of Membrane-Bound TROP2 in TROPION-Lung01 Underscores Seminal Advance in Lung Cancer Digital Pathology
• FURTHER Study Moves the Needle Farther on Targeted Therapy Directed at Atypical EGFR Mutations in NSCLC
• Aumolertinib After CRT Significantly Improves PFS in EGFR-mutated Unresectable NSCLC
• Second Presidential Symposium to Focus on Latest in Targeted Therapy Research
• Challenging Patient Outcomes Can Cause Oncologists to Question Their Skills
• Meet the Expert: Radiological Challenges in Lung Cancer
• Self-Learning AI as a Diagnostic Tool in Malignant Mesothelioma
• IASLC Journals See Continued Success Throughout Past Year
• Hands-on Workshop Outlines Challenges and Potential Solutions for Translating Early Detection Biomarkers From Discovery to Lung Cancer Clinical Practice
• Updated Biomarker Survey Results Show Paradigm Shift As More Respondents Now Consider Testing a “Must Have”
• 9th Edition Lung Cancer Staging Recommendations to be Explained
• Special Plenary to Focus on IASLC’s Role in Shaping Thoracic Cancer Research, Treatment
• IASLC Lectureships Focus on Contributions of Leaders in Thoracic Oncology
• Session to Report Results of IASLC’s First Diversity, Equity, and Inclusion Survey
• IASLC Award Recognizes Importance of Teamwork in Cancer Care
• Don’t Miss Your Last Chance to Visit the Exhibit Hall
• Order Your Copy of the IASLC 50th Anniversary History Book Today
• HARMONi-2 Study Findings May Reshape the Therapeutic Paradigm of Frontline Driver Mutation-Negative Advanced NSCLC
• NeoCOAST-2 Shows Pathologic Response Benefit for Perioperative Durvalumab + ADC + Chemotherapy Combination
• Plenary Session Will Unveil Impact of Non-Tobacco Factors in Lung Cancer Risk
• Lung Cancer Beyond Smoking: Outdoor Air Pollution and Lung Cancer
• Surgical Challenges and Opportunities in Locally Advanced NSCLC
• Closing Plenary Will Focus on the Importance of Advancing Patient Advocacy

IASLC Lung Cancer News (ILCN) is the offical news source of the only global association dedicated to the multidisciplinary study of lung cancer, published bimonthly by the International Association for the Study of Lung Cancer (IASLC). 

Click here to link to Submission Guidelines.